Why Novo Nordisk Stock Is Sinking This Week
Werte in diesem Artikel
The stock price for Danish drugmaker Novo Nordisk (NYSE: NVO) is down more than 8% since last Friday's close. What's going on with this former darling of the global pharmaceutical industry that surged in recent years to become Europe's most valuable company?Well, several things, in fact.On Wednesday (Nov. 5), the maker of popular GLP-1 drugs Ozempic and Wegovy announced third-quarter results, and they did not impress.Continue readingWeiter zum vollständigen Artikel bei MotleyFool
Quelle: MotleyFool
